Amarin Corp Plc (AMRN)

[couldbebetter]

Market dynamics are such that any BP on the planet right now could afford AMRN
right now. The question becomes can Denner force a sale of AMRN if the BOD is
resistant? Then, how many BP are interested in a BO of AMRN or truly understand
the potential? My answer is at least two:
1. BMY (With Dr. Bhatt on its BOD.)
2. PFE (Given their partnership arrangement with HLS.)
From there one can add NVS, MRK, LLY, Biogen, Bayer, AZN (not so much given
idiot Nissen's obstinance in accepting Reduce-It results,) Roche (that just ditched
an Alzheimer's drug,) GSK, AMGN, Novo-Nordisk, and I'm sure I missed a few.

One wonders if perhaps Denner put out any feelers before he made his
investment in AMRN. What if he did and the answer was if was for sale
at a reasonable price they would be interested. The Catch-22 may be that
the sales of Vazkepa will not take off until it is owned by BP...Yet some posters
here believe that AMRN must prove up sales first before BP would make a bid.